Your browser doesn't support javascript.
loading
Initial motor reserve and long-term prognosis in Parkinson's disease.
Chung, Seok Jong; Yoo, Han Soo; Lee, Yang Hyun; Lee, Hye Sun; Lee, Phil Hyu; Sohn, Young H.
Afiliação
  • Chung SJ; Department of Neurology, Yonsei University College of Medicine, Seoul, South Korea; Department of Neurology, Yongin Severance Hospital, Yonsei University Health System, Yongin, South Korea.
  • Yoo HS; Department of Neurology, Yonsei University College of Medicine, Seoul, South Korea.
  • Lee YH; Department of Neurology, Yonsei University College of Medicine, Seoul, South Korea.
  • Lee HS; Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, South Korea.
  • Lee PH; Department of Neurology, Yonsei University College of Medicine, Seoul, South Korea.
  • Sohn YH; Department of Neurology, Yonsei University College of Medicine, Seoul, South Korea. Electronic address: yhsohn62@yuhs.ac.
Neurobiol Aging ; 92: 1-6, 2020 08.
Article em En | MEDLINE | ID: mdl-32320836
ABSTRACT
There are individual differences in motor deficits, despite a similar degree of dopamine neuronal loss in Parkinson's disease (PD), called motor reserve (MR). Factors enhancing MR have been documented previously, but the influence of initial MR on the long-term prognosis remains unclear. In this longitudinal study, we enrolled 205 patients with de novo PD to estimate individual MR based on initial motor deficits and striatal dopamine depletion using the residual-based approach. We assessed the risk of developing levodopa-induced dyskinesia (LID) or freezing of gait (FOG) and longitudinal increases in levodopa-equivalent dose (LED) according to MR estimates using the Cox regression model and linear mixed model, respectively. Throughout the follow-up period (≥3 years), greater MR estimates were associated with a lower risk for LID and FOG. In addition, patients with high MR received lower LED than those with low MR. These findings suggest that the initial MR, that is, individual's capacity to cope with PD-related pathologies, can be maintained with disease progression and can modulate the risk for LID or FOG.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Levodopa / Discinesias / Transtornos Neurológicos da Marcha / Atividade Motora Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Levodopa / Discinesias / Transtornos Neurológicos da Marcha / Atividade Motora Idioma: En Ano de publicação: 2020 Tipo de documento: Article